admin

Jumia Technologies AG (NYSE:JMIA) stock’s movement earlier in 2021 can be described in just three words. Pump and dump. Source: Christopher Penler / Shutterstock.com Sounds familiar? It should. If not, here’s a quick reminder. Wikipedia mentions that it “involves artificially inflating the price of an owned stock through false and misleading positive statements, to sell
0 Comments
Support.com (NASDAQ:SPRT) holds its special meeting on Sept. 10 to vote on its merger with Greenridge Generation Holdings. The merger’s acceptance requires that more than 50% of owners of SPRT stock vote to approve the deal. Source: Shutterstock.com The two parties announced their merger on March 22. The day before the merger announcement, SPRT closed
0 Comments
Oil prices pushed past $70 for the first time in a month in late-day trading Thursday. The rally is breathing new life into the energy sector, which is up 2.5% at this writing. For the past quarter, energy stocks have been lagging the broader market, so shareholders are cheering the newfound strength. To celebrate the
0 Comments
When the Bank of Japan (BOJ) announced a policy of negative interest rates in 2016 by charging interest on reserve deposits, yields on Japanese government debt fell precipitously. The yield on 10-year Japanese government bonds fell to a record negative 0.135%, below the BOJ’s negative 0.1% reserve deposit rate. With the BOJ purchasing government bonds at an unprecedented annual rate
0 Comments
A leader in the online sports gambling industry, DraftKings (NASDAQ:DKNG) is expanding its presence across the States and is expected to benefit from the upcoming football season. The company is making well-timed moves to build new offerings and achieve growth. It has successfully partnered with some of the top sports companies to offer a unique experience
0 Comments
Have you seen gene editing and sequencing stocks recently? Source: Connect world / Shutterstock.com Illumina (NASDAQ:ILMN) is up 20% over the past three months. Beam Therapeutics (NASDAQ:BEAM) is up 45%. Editas Medicine (NASDAQ:EDIT) is up 90%. Intellia Therapeutics (NASDAQ:NTLA) is up 150%. Folks, the Genomic Revolution is here. And while everyone can see those big
0 Comments